MX2016011808A - Derivados de hexosa, preparacion y usos de los mismos. - Google Patents
Derivados de hexosa, preparacion y usos de los mismos.Info
- Publication number
- MX2016011808A MX2016011808A MX2016011808A MX2016011808A MX2016011808A MX 2016011808 A MX2016011808 A MX 2016011808A MX 2016011808 A MX2016011808 A MX 2016011808A MX 2016011808 A MX2016011808 A MX 2016011808A MX 2016011808 A MX2016011808 A MX 2016011808A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- hexose derivatives
- hexose
- derivatives
- ch2c
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Abstract
Se describe un compuesto de la fórmula I: o una sal de los mismos, en donde: R1 es -OC(H) (X) (CH2)nC(=O)OH; R2 es -OH, -N3, o -N(H)C(=O)CH3 o R1 y R2 junto con los átomos de carbono a los cuales se enlazan forman R3 es -H, -CH3, -CH2C (=O) OH, o -CH2OH; X es -H, -CH3, -CH2OH, o CH2C (=O) OH; y n es 0 o 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461953392P | 2014-03-14 | 2014-03-14 | |
PCT/PT2015/050001 WO2015137838A1 (en) | 2014-03-14 | 2015-03-13 | Hexose derivatives, preparation and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016011808A true MX2016011808A (es) | 2017-05-09 |
Family
ID=53264710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016011808A MX2016011808A (es) | 2014-03-14 | 2015-03-13 | Derivados de hexosa, preparacion y usos de los mismos. |
Country Status (12)
Country | Link |
---|---|
US (2) | US11708387B2 (es) |
EP (1) | EP3116886A1 (es) |
JP (2) | JP7067867B2 (es) |
KR (3) | KR102401853B1 (es) |
CN (2) | CN115448964A (es) |
BR (1) | BR112016021231B1 (es) |
CA (1) | CA2942635C (es) |
IL (1) | IL247531B (es) |
MX (1) | MX2016011808A (es) |
RU (1) | RU2731563C2 (es) |
SG (2) | SG11201607530XA (es) |
WO (1) | WO2015137838A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115448964A (zh) * | 2014-03-14 | 2022-12-09 | 里斯本大学科学与技术学院 | 己糖衍生物及其制剂和用途 |
FR3061013B1 (fr) * | 2016-12-22 | 2020-04-17 | Greenpharma | Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique |
CN111683957A (zh) * | 2017-11-13 | 2020-09-18 | 埃克斯特雷莫凯姆有限公司 | 作为用于生物分子的稳定剂的中性糖基化酰胺和双阴离子葡萄糖醛酸化的酸 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060099567A1 (en) | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
PT103442A (pt) | 2006-02-24 | 2007-08-31 | Stab Vida Investigacao E Servi | Derivados sintéticos de manosil-glicerato para a estabilização e/ou preservação de biomateriais |
PT103441A (pt) | 2006-02-24 | 2007-08-24 | Stab Vida Investigacao E Servi | Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados |
DE102010038496A1 (de) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilisierte flüssige enzymhaltige Tensidzubereitung |
DE102011118027A1 (de) * | 2011-09-12 | 2013-03-14 | Henkel Ag & Co. Kgaa | Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente |
CN115448964A (zh) | 2014-03-14 | 2022-12-09 | 里斯本大学科学与技术学院 | 己糖衍生物及其制剂和用途 |
JP2020097767A (ja) | 2018-12-18 | 2020-06-25 | 株式会社東芝 | 表面処理剤、これを用いた積層体、及び無電解めっき製品 |
-
2015
- 2015-03-13 CN CN202211044372.5A patent/CN115448964A/zh active Pending
- 2015-03-13 US US15/125,522 patent/US11708387B2/en active Active
- 2015-03-13 EP EP15724386.6A patent/EP3116886A1/en active Pending
- 2015-03-13 RU RU2016140337A patent/RU2731563C2/ru active
- 2015-03-13 JP JP2016575290A patent/JP7067867B2/ja active Active
- 2015-03-13 MX MX2016011808A patent/MX2016011808A/es unknown
- 2015-03-13 SG SG11201607530XA patent/SG11201607530XA/en unknown
- 2015-03-13 SG SG10201807891UA patent/SG10201807891UA/en unknown
- 2015-03-13 BR BR112016021231-2A patent/BR112016021231B1/pt active IP Right Grant
- 2015-03-13 KR KR1020167028609A patent/KR102401853B1/ko active IP Right Grant
- 2015-03-13 WO PCT/PT2015/050001 patent/WO2015137838A1/en active Application Filing
- 2015-03-13 KR KR1020247009385A patent/KR20240045328A/ko active Search and Examination
- 2015-03-13 CA CA2942635A patent/CA2942635C/en active Active
- 2015-03-13 CN CN201580014386.4A patent/CN106573952A/zh active Pending
- 2015-03-13 KR KR1020227017066A patent/KR102651029B1/ko active IP Right Grant
-
2016
- 2016-08-29 IL IL247531A patent/IL247531B/en active IP Right Grant
-
2020
- 2020-06-04 JP JP2020097767A patent/JP7077361B2/ja active Active
-
2023
- 2023-06-09 US US18/332,157 patent/US20230357301A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IL247531B (en) | 2021-04-29 |
KR102401853B1 (ko) | 2022-05-25 |
CA2942635C (en) | 2022-12-06 |
JP7077361B2 (ja) | 2022-05-30 |
US11708387B2 (en) | 2023-07-25 |
WO2015137838A1 (en) | 2015-09-17 |
BR112016021231A2 (pt) | 2018-07-10 |
US20230357301A1 (en) | 2023-11-09 |
JP2017516838A (ja) | 2017-06-22 |
RU2016140337A (ru) | 2018-04-17 |
SG10201807891UA (en) | 2018-10-30 |
JP7067867B2 (ja) | 2022-05-16 |
JP2020183383A (ja) | 2020-11-12 |
IL247531A0 (en) | 2016-11-30 |
CN115448964A (zh) | 2022-12-09 |
KR102651029B1 (ko) | 2024-03-25 |
CA2942635A1 (en) | 2015-09-17 |
KR20220153571A (ko) | 2022-11-18 |
KR20240045328A (ko) | 2024-04-05 |
BR112016021231B1 (pt) | 2021-07-27 |
CN106573952A (zh) | 2017-04-19 |
RU2731563C2 (ru) | 2020-09-04 |
RU2016140337A3 (es) | 2018-10-30 |
EP3116886A1 (en) | 2017-01-18 |
KR20160145584A (ko) | 2016-12-20 |
US20180170955A1 (en) | 2018-06-21 |
SG11201607530XA (en) | 2016-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR117799A2 (es) | Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración | |
WO2016077464A8 (en) | Amino acid derivatives and their uses | |
BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
IN2015MN00404A (es) | ||
PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
EA201790810A1 (ru) | Активная композиция для мягчителя ткани | |
BR112017008176A2 (pt) | método de preparação do carbonato de ácido glicérico. | |
CR20130501A (es) | Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos | |
BR112015020904A2 (pt) | microrganismos e métodos para produção de butadieno e compostos relacionados por assimilação de formiato | |
MX364069B (es) | Moduladores de la proteína activadora de 5-lipoxigenasa. | |
PH12019501178A1 (en) | Thiopene derivatives as antiviral agents | |
PH12014502752A1 (en) | Novel cyclic depsipeptide derivative and pest control agent compromising same | |
UA113656C2 (xx) | Гербіцидна композиція, яка має поліпшену гербіцидну активність | |
CO6590210A1 (es) | Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina | |
MX2015013807A (es) | Produccion de piripiropenos a partir de biomasa seca. | |
PH12016500461A1 (en) | Polyethylene glycol-containing composition | |
MX2016011808A (es) | Derivados de hexosa, preparacion y usos de los mismos. | |
EA201692270A1 (ru) | Производные нафтиридиндиона | |
MX2016015515A (es) | Aducto de monogicidil eter de maltodextrina. | |
SG10201805880UA (en) | Emulsion composition for skin | |
EA201690467A1 (ru) | Промышленный способ синтеза улипристала ацетата и его 4'-ацетильного аналога | |
PH12014501676B1 (en) | Plant disease control composition | |
PH12018500014A1 (en) | Total synthesis of shishijimicin a and analogs thereof | |
MX2018015269A (es) | Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos. | |
MX2018006572A (es) | Compuestos. |